Adenocarcinoma do colo do útero: um verdadeiro desafio clínico

Detalhes bibliográficos
Autor(a) principal: Santos,Fernanda
Data de Publicação: 2018
Outros Autores: Pacheco,Mª Amália, Morera,José Luis Enriquez, Lagoa,António Augusto
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100002
Resumo: Overview and Aims: Cervical cancer is the fourth most frequent cancer in women worldwide, with 266.000 death cases in 2012. The epidermoid cancers are more prevalent, but the incidence of adenocarcinomas and its variants has increased over the past few decades, especially in young women. Problems impacting the diagnosis of cervical glandular lesions include reduced sensitivity of screening with cervical cytology, colposcopic inexperience and subtle colposcopic findings. This study aimed to evaluate in situ and invasive cervical adenocarcinoma cases with regards to relations between risk factors, prognostic factors and mortality. Study Design: Cross-sectional study. Methods: 28 women diagnosed with cervical adenocarcinoma, were revised. The diagnose was made at a tertiary center, from January 2009 to December 2015. Statistical analysis was performed by STATA 13.1 program. Results: Ten cervical adenocarcinoma in situ (AIS) and eighteen invasive adenocarcinoma (IA), were analyzed. It was identified statistical difference in the diagnostic age (AIS: median 39 years; IA: median 51 years), number of previous cervical cytologies (AIS: 80% performed screening vs IA: 50% no screening) and cytology findings (AIS: 63% Atypical glandular cells vs IA: 50% adenocarcinoma). There was no relation with obesity, hormonal contraception, smoking and number of sexual partners. It was identified statistical significance between prognosis and FIGO stage (55.6% Stage1). Five deaths were reported (IB1:1, IIA1: 2 e IVB:2) and also one successful pregnancy (IA1). Conclusion: In this study, it was not identified relation with risk factors and only FIGO stage statistically contributes to prognosis.
id RCAP_94a230f29ef4b50f31bf46f082797577
oai_identifier_str oai:scielo:S1646-58302018000100002
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Adenocarcinoma do colo do útero: um verdadeiro desafio clínicoAdenocarcinomaCervix uteriDiagnosis and treatmentOverview and Aims: Cervical cancer is the fourth most frequent cancer in women worldwide, with 266.000 death cases in 2012. The epidermoid cancers are more prevalent, but the incidence of adenocarcinomas and its variants has increased over the past few decades, especially in young women. Problems impacting the diagnosis of cervical glandular lesions include reduced sensitivity of screening with cervical cytology, colposcopic inexperience and subtle colposcopic findings. This study aimed to evaluate in situ and invasive cervical adenocarcinoma cases with regards to relations between risk factors, prognostic factors and mortality. Study Design: Cross-sectional study. Methods: 28 women diagnosed with cervical adenocarcinoma, were revised. The diagnose was made at a tertiary center, from January 2009 to December 2015. Statistical analysis was performed by STATA 13.1 program. Results: Ten cervical adenocarcinoma in situ (AIS) and eighteen invasive adenocarcinoma (IA), were analyzed. It was identified statistical difference in the diagnostic age (AIS: median 39 years; IA: median 51 years), number of previous cervical cytologies (AIS: 80% performed screening vs IA: 50% no screening) and cytology findings (AIS: 63% Atypical glandular cells vs IA: 50% adenocarcinoma). There was no relation with obesity, hormonal contraception, smoking and number of sexual partners. It was identified statistical significance between prognosis and FIGO stage (55.6% Stage1). Five deaths were reported (IB1:1, IIA1: 2 e IVB:2) and also one successful pregnancy (IA1). Conclusion: In this study, it was not identified relation with risk factors and only FIGO stage statistically contributes to prognosis.Euromédice, Edições Médicas Lda.2018-03-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100002Acta Obstétrica e Ginecológica Portuguesa v.12 n.1 2018reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100002Santos,FernandaPacheco,Mª AmáliaMorera,José Luis EnriquezLagoa,António Augustoinfo:eu-repo/semantics/openAccess2024-02-06T17:21:40Zoai:scielo:S1646-58302018000100002Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:28:37.582261Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
title Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
spellingShingle Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
Santos,Fernanda
Adenocarcinoma
Cervix uteri
Diagnosis and treatment
title_short Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
title_full Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
title_fullStr Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
title_full_unstemmed Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
title_sort Adenocarcinoma do colo do útero: um verdadeiro desafio clínico
author Santos,Fernanda
author_facet Santos,Fernanda
Pacheco,Mª Amália
Morera,José Luis Enriquez
Lagoa,António Augusto
author_role author
author2 Pacheco,Mª Amália
Morera,José Luis Enriquez
Lagoa,António Augusto
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos,Fernanda
Pacheco,Mª Amália
Morera,José Luis Enriquez
Lagoa,António Augusto
dc.subject.por.fl_str_mv Adenocarcinoma
Cervix uteri
Diagnosis and treatment
topic Adenocarcinoma
Cervix uteri
Diagnosis and treatment
description Overview and Aims: Cervical cancer is the fourth most frequent cancer in women worldwide, with 266.000 death cases in 2012. The epidermoid cancers are more prevalent, but the incidence of adenocarcinomas and its variants has increased over the past few decades, especially in young women. Problems impacting the diagnosis of cervical glandular lesions include reduced sensitivity of screening with cervical cytology, colposcopic inexperience and subtle colposcopic findings. This study aimed to evaluate in situ and invasive cervical adenocarcinoma cases with regards to relations between risk factors, prognostic factors and mortality. Study Design: Cross-sectional study. Methods: 28 women diagnosed with cervical adenocarcinoma, were revised. The diagnose was made at a tertiary center, from January 2009 to December 2015. Statistical analysis was performed by STATA 13.1 program. Results: Ten cervical adenocarcinoma in situ (AIS) and eighteen invasive adenocarcinoma (IA), were analyzed. It was identified statistical difference in the diagnostic age (AIS: median 39 years; IA: median 51 years), number of previous cervical cytologies (AIS: 80% performed screening vs IA: 50% no screening) and cytology findings (AIS: 63% Atypical glandular cells vs IA: 50% adenocarcinoma). There was no relation with obesity, hormonal contraception, smoking and number of sexual partners. It was identified statistical significance between prognosis and FIGO stage (55.6% Stage1). Five deaths were reported (IB1:1, IIA1: 2 e IVB:2) and also one successful pregnancy (IA1). Conclusion: In this study, it was not identified relation with risk factors and only FIGO stage statistically contributes to prognosis.
publishDate 2018
dc.date.none.fl_str_mv 2018-03-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100002
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100002
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Euromédice, Edições Médicas Lda.
publisher.none.fl_str_mv Euromédice, Edições Médicas Lda.
dc.source.none.fl_str_mv Acta Obstétrica e Ginecológica Portuguesa v.12 n.1 2018
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137355776393216